...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Chronic Obstructive Pulmonary Diseaseand COVID-19: A Double Trouble
【24h】

Chronic Obstructive Pulmonary Diseaseand COVID-19: A Double Trouble

机译：慢性阻塞性肺病和Covid-19：双重麻烦

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Coronavirus Disease 2019 (COVID-19) is a respiratory and systemic illness that may progress to severe Acute Respiratory Distress Syndrome (ARDS). There is a pressing need to identify clinical predictors of severe COVID-19 which can help in risk stratification and prognostication. The COVID-19 pandemic tends to have more severe clinical presentation in older age group and in chronic diseases; Chronic Obstructive Pulmonary Disease (COPD) is one of them. COPD is the common cause of high mortality and morbidity worldwide. It is obvious to fear for patients with underlying COPD. Acute episode of exacerbation and COVID-19 pneumonia are the two pivotal differential diagnoses in contemporary era, in patients of COPD presenting with worsening dyspnoea. Mortality rate have been higher among COPD group of patients with the development of hypoxemia. Literature shows that pre-existing COPD worsens the risk of COVID-19 progression and leads to poorer prognosis. Even after recovery from the acute event, proper adherence to maintenance therapy for COPD (inhalational agents) continues to be of paramount importance and remains the standard of care. Because COPD remains a subset that is highly vulnerable for adverse outcomes with COVID-19 infection, preventive therapy should be directed towards–attenuation of contact with droplets, proper hand hygiene and maintenance of adequate nutritional status. The aim of this brief review is to know the burden and impact of COPD on COVID-19 pandemic and challenges in diagnosis and management of COPD patients.
机译：冠状病毒疾病2019（Covid-19）是一种呼吸系统和全身疾病，可能对严重的急性呼吸窘迫综合征（ARDS）进行。迫切需要识别严重Covid-19的临床预测因子，可以有助于风险分层和预后。 Covid-19大流行倾向于在老年龄群和慢性疾病中具有更严重的临床介绍;慢性阻塞性肺病（COPD）是其中之一。 COPD是全世界死亡率高的常见原因和发病率。对于潜在的COPD患者来说，很明显。加剧和Covid-19肺炎的急性发作是当代时代的两种关键鉴别诊断，患有恶化的呼吸困难患者。 COPD患者患者缺氧血症患者中的死亡率较高。文献表明，预先存在的COPD恶化了Covid-19进展的风险，并导致预后较差。即使从急性事件中恢复后，适当遵守对COPD（吸入剂）的维持治疗仍然是至关重要的，并且仍然是护理标准。由于COPD仍然是具有Covid-19感染不良结果的弱势群体，因为预防治疗应该被引导 - 与液滴的接触，适当的手工卫生和适当的营养状况的维持逐渐衰减。本简要审查的目的是了解COPD对Covid-19诊断和管理诊断和管理挑战的负担和影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号